Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen M Boyle

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Expert Review of Anticancer Therapy|May 11, 2011
Therapy for metastatic melanoma: an overview and updateGlen M Boyle
The Laryngoscope|August 11, 2015
Novel mouse model for simulating microsurgical tumor excision with facial nerve preservationJae H Lim, Glen M Boyle, Benedict Panizza
The Journal of Investigative Dermatology|November 15, 2013
Evidence for an alternatively spliced MITF exon 2 variantJacinta L Simmons, Carly J Pierce, Glen M Boyle
Cancers|June 24, 2022
Heterogeneity in MelanomaMei Fong Ng, Jacinta L Simmons, Glen M Boyle
Pigment Cell Research|May 17, 2005
Histone deacetylase inhibitors and malignant melanomaGlen M Boyle, Adam C Martyn, Peter G Parsons
Experimental Dermatology|October 29, 2020
BRN2 and MITF together impact AXL expression in melanomaJacinta L Simmons, Hannah M Neuendorf, Glen M Boyle
Plos One|April 17, 2015
Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cellsDanielle Bartlett, Glen M Boyle, Mel Ziman, et al.
Frontiers in Cell and Developmental Biology|May 14, 2023
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasisHannah M Neuendorf, Jacinta L Simmons, Glen M Boyle
Scientific Reports|November 9, 2019
Kunitz type protease inhibitor from the canine tapeworm as a potential therapeutic for melanomaShiwanthi L Ranasinghe, Vanessa Rivera, Glen M Boyle, et al.
British Journal of Plastic Surgery|March 10, 2004
What is transforming growth factor-beta (TGF-beta)?David Chin, Glen M Boyle, Peter G Parsons, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Expert Review of Anticancer Therapy|May 11, 2011
Therapy for metastatic melanoma: an overview and updateGlen M Boyle
The Laryngoscope|August 11, 2015
Novel mouse model for simulating microsurgical tumor excision with facial nerve preservationJae H Lim, Glen M Boyle, Benedict Panizza
The Journal of Investigative Dermatology|November 15, 2013
Evidence for an alternatively spliced MITF exon 2 variantJacinta L Simmons, Carly J Pierce, Glen M Boyle
Cancers|June 24, 2022
Heterogeneity in MelanomaMei Fong Ng, Jacinta L Simmons, Glen M Boyle
Pigment Cell Research|May 17, 2005
Histone deacetylase inhibitors and malignant melanomaGlen M Boyle, Adam C Martyn, Peter G Parsons
Experimental Dermatology|October 29, 2020
BRN2 and MITF together impact AXL expression in melanomaJacinta L Simmons, Hannah M Neuendorf, Glen M Boyle
Plos One|April 17, 2015
Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cellsDanielle Bartlett, Glen M Boyle, Mel Ziman, et al.
Frontiers in Cell and Developmental Biology|May 14, 2023
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasisHannah M Neuendorf, Jacinta L Simmons, Glen M Boyle
Scientific Reports|November 9, 2019
Kunitz type protease inhibitor from the canine tapeworm as a potential therapeutic for melanomaShiwanthi L Ranasinghe, Vanessa Rivera, Glen M Boyle, et al.
British Journal of Plastic Surgery|March 10, 2004
What is transforming growth factor-beta (TGF-beta)?David Chin, Glen M Boyle, Peter G Parsons, et al.
Pageof 12